Your browser doesn't support javascript.
loading
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.
Legros, Vincent; Denolly, Solène; Vogrig, Manon; Boson, Bertrand; Siret, Eglantine; Rigaill, Josselin; Pillet, Sylvie; Grattard, Florence; Gonzalo, Sylvie; Verhoeven, Paul; Allatif, Omran; Berthelot, Philippe; Pélissier, Carole; Thiery, Guillaume; Botelho-Nevers, Elisabeth; Millet, Guillaume; Morel, Jérôme; Paul, Stéphane; Walzer, Thierry; Cosset, François-Loïc; Bourlet, Thomas; Pozzetto, Bruno.
Afiliación
  • Legros V; CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Denolly S; Université de Lyon, VetAgro Sup, Marcy-l'Étoile, France.
  • Vogrig M; CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Boson B; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Siret E; Department of Immunology, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Rigaill J; CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Pillet S; CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Grattard F; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Gonzalo S; Department of Immunology, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Verhoeven P; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Allatif O; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Berthelot P; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Pélissier C; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Thiery G; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Botelho-Nevers E; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Millet G; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Morel J; CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Paul S; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
  • Walzer T; Department of Infectious Diseases, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Cosset FL; Department of Occupational Medicine, University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Bourlet T; Department of Intensive Care and Resuscitation (Réanimation G), University-Hospital of Saint-Etienne, Saint-Etienne, France.
  • Pozzetto B; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, F-69007, Lyon, France.
Cell Mol Immunol ; 18(2): 318-327, 2021 02.
Article en En | MEDLINE | ID: mdl-33408342
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Anticuerpos Neutralizantes / Prueba Serológica para COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Anticuerpos Neutralizantes / Prueba Serológica para COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: China